TR200003350T2 - New formulation containing paroxetine. - Google Patents

New formulation containing paroxetine.

Info

Publication number
TR200003350T2
TR200003350T2 TR2000/03350T TR200003350T TR200003350T2 TR 200003350 T2 TR200003350 T2 TR 200003350T2 TR 2000/03350 T TR2000/03350 T TR 2000/03350T TR 200003350 T TR200003350 T TR 200003350T TR 200003350 T2 TR200003350 T2 TR 200003350T2
Authority
TR
Turkey
Prior art keywords
formulation containing
new formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
TR2000/03350T
Other languages
Turkish (tr)
Inventor
David Elder Philip
Stanley Leonard Garham
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200003350T2 publication Critical patent/TR200003350T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Imalat prosesi sirasinda hemihidrata belirgin bir dönüsüm olmayacak sekilde tabetler halinde formüle edilen, hemihidrat disinda bir formda olan paroksetin hidroklorid.Paroxetine hydrochloride, which is formulated in tabs such that there is no significant conversion to hemihydrate during the manufacturing process, which is in a form other than hemihydrate.

TR2000/03350T 1998-05-13 1999-05-13 New formulation containing paroxetine. TR200003350T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations

Publications (1)

Publication Number Publication Date
TR200003350T2 true TR200003350T2 (en) 2001-03-21

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03350T TR200003350T2 (en) 1998-05-13 1999-05-13 New formulation containing paroxetine.

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
WO1998031365A1 (en) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Paroxetine compositions
EP1047407A4 (en) * 1997-12-19 2007-05-02 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets

Also Published As

Publication number Publication date
SK17142000A3 (en) 2001-06-11
NO20005683D0 (en) 2000-11-10
ID28019A (en) 2001-05-03
WO1999058113A3 (en) 2000-02-17
PL344573A1 (en) 2001-11-05
KR20010043574A (en) 2001-05-25
CN1308521A (en) 2001-08-15
HUP0102064A2 (en) 2002-05-29
AP2000002019A0 (en) 2000-12-31
GB9810181D0 (en) 1998-07-08
NO20005683L (en) 2000-12-05
EA200001174A1 (en) 2001-06-25
IL139594A0 (en) 2002-02-10
JP2002514591A (en) 2002-05-21
BR9910401A (en) 2001-01-09
BG105010A (en) 2001-07-31
AU3940999A (en) 1999-11-29
CA2331871A1 (en) 1999-11-18
EP1077682A2 (en) 2001-02-28
WO1999058113A2 (en) 1999-11-18
ZA200006562B (en) 2002-02-13

Similar Documents

Publication Publication Date Title
TR200102800T2 (en) New compounds.
DE69939958D1 (en) Accelerator suitable for energy polymerizable compositions
EA200500017A1 (en) NEW CONNECTIONS
BR0116402A (en) Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
CY1108567T1 (en) ANTI-THROUGH UNITS
TR200200460T2 (en) New phenylpiperazines
MX9700273A (en) Substituted benzamidines, their production and their use as medicaments.
DE69835773D1 (en) WATER-COMPATIBLE ENERGY-HARDENABLE COMPOSITIONS CONTAINING MALEIMID DERIVATIVES
TR200001472T2 (en) Method for the preparation of 8-methoxy-quinolone-carboxylic acids
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
TR200201688T2 (en) Citalopram preparation method.
TR199902929T2 (en) The new process.
DE69902811T2 (en) SELF-HEALING OBJECTS RESISTANT TO STRONG OXIDIZERS
TR200003351T2 (en) New formulation containing paroxetine
TR200003350T2 (en) New formulation containing paroxetine.
BR0012751A (en) Serotonergic benzofurans
TR200402547T4 (en) A process for preparing pantoprazole and its intermediates.
ID30351A (en) 2,3-0-ISOPROPYLIDENE MONOSAKARIDA DERIVATIPES AS A OBSTERENCE OF CELL ADHESIVES
DE69939424D1 (en) Perfumed detergent tablet
IL145339A0 (en) New technology for improving the utilization of sunlight by plants
DK1206452T3 (en) Process for the preparation of benzoperhydroisoindole compounds
IT1293777B1 (en) PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES
TR200000624T2 (en) A method for increasing the effectiveness of an enzyme.
ID27440A (en) PROCESS FOR PREPARING
DE59803066D1 (en) SUBSTITUTED BENZYLOXYIMINO COMPOUNDS